- Home
- IH vs TLSA Comparison
IH vs TLSA Comparison
Compare IH & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IH
- TLSA
- Stock Information
- Founded
- IH 1996
- TLSA 2013
- Country
- IH China
- TLSA United Kingdom
- Employees
- IH N/A
- TLSA N/A
- Industry
- IH Other Consumer Services
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- IH Real Estate
- TLSA Health Care
- Exchange
- IH Nasdaq
- TLSA Nasdaq
- Market Cap
- IH 123.1M
- TLSA 187.0M
- IPO Year
- IH 2020
- TLSA 2000
- Fundamental
- Price
- IH $2.28
- TLSA $1.45
- Analyst Decision
- IH
- TLSA
- Analyst Count
- IH 0
- TLSA 0
- Target Price
- IH N/A
- TLSA N/A
- AVG Volume (30 Days)
- IH 18.3K
- TLSA 246.7K
- Earning Date
- IH 06-26-2025
- TLSA 07-22-2025
- Dividend Yield
- IH 3.70%
- TLSA N/A
- EPS Growth
- IH N/A
- TLSA N/A
- EPS
- IH 0.26
- TLSA N/A
- Revenue
- IH $123,701,096.00
- TLSA N/A
- Revenue This Year
- IH $39.02
- TLSA N/A
- Revenue Next Year
- IH N/A
- TLSA N/A
- P/E Ratio
- IH $8.74
- TLSA N/A
- Revenue Growth
- IH N/A
- TLSA N/A
- 52 Week Low
- IH $1.47
- TLSA $0.63
- 52 Week High
- IH $3.18
- TLSA $1.91
- Technical
- Relative Strength Index (RSI)
- IH 43.26
- TLSA 48.43
- Support Level
- IH $2.20
- TLSA $1.43
- Resistance Level
- IH $2.70
- TLSA $1.81
- Average True Range (ATR)
- IH 0.13
- TLSA 0.09
- MACD
- IH -0.02
- TLSA -0.02
- Stochastic Oscillator
- IH 14.42
- TLSA 18.53
About IH iHuman Inc.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.